Amneal Pharmaceuticals Operating Expenses 2011-2026 | AMRX

Annual Operating Expenses Amneal Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	539 M	480 M	301 M	324 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
539 M	301 M	411 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Agenus AGEN	46 M	$ 3.27	-1.8 %	$ 1.17 M	USA
Agios Pharmaceuticals AGIO	543 M	$ 29.33	-2.98 %	$ 1.7 B	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Akebia Therapeutics AKBA	173 M	$ 1.26	-3.44 %	$ 324 M	USA
Akari Therapeutics, Plc AKTX	21.6 M	$ 0.24	1.1 %	$ 5.73 B	Britain
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Aldeyra Therapeutics ALDX	34.7 M	$ 5.49	0.52 %	$ 330 M	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Alector ALEC	177 M	$ 2.26	-7.2 %	$ 233 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Aligos Therapeutics ALGS	104 M	$ 7.02	-0.21 %	$ 451 M	USA
Alkermes plc ALKS	640 M	$ 29.32	-2.61 %	$ 4.83 B	Irlanda
Allogene Therapeutics ALLO	328 M	$ 2.57	-7.73 %	$ 403 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Alnylam Pharmaceuticals ALNY	1.13 B	$ 330.95	-0.59 %	$ 43.4 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Altimmune ALT	103 M	$ 4.2	-2.55 %	$ 298 M	USA
ALX Oncology Holdings ALXO	142 M	$ 2.11	0.09 %	$ 110 M	USA
Amgen AMGN	9.33 B	$ 387.85	0.03 %	$ 209 B	USA
Amphastar Pharmaceuticals AMPH	216 M	$ 20.22	-0.05 %	$ 945 M	USA
Amarin Corporation plc AMRN	233 M	$ 13.62	-1.3 %	$ 5.55 B	Irlanda
AIM ImmunoTech AIM	14.4 M	$ 0.92	5.25 %	$ 44.2 M	USA
AnaptysBio ANAB	206 M	$ 54.61	-0.8 %	$ 1.55 B	USA
Anika Therapeutics ANIK	51.6 M	$ 14.44	0.53 %	$ 212 M	USA
ANI Pharmaceuticals ANIP	127 M	$ 75.31	1.91 %	$ 1.45 B	USA
Annexon ANNX	154 M	$ 5.38	-3.93 %	$ 739 M	USA
Annovis Bio ANVS	45 M	$ 2.6	-2.99 %	$ 23.5 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Apellis Pharmaceuticals APLS	948 M	$ 20.53	-2.05 %	$ 2.59 B	USA
Aptorum Group Limited APM	20.7 M	$ 0.78	-0.67 %	$ 4.25 M	China
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Aprea Therapeutics APRE	16.1 M	$ 0.88	-3.71 %	$ 3.18 M	USA
Aptevo Therapeutics APVO	-31.8 M	$ 7.28	-0.55 %	$ 2.01 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Aquestive Therapeutics AQST	85.5 M	$ 3.99	-0.15 %	$ 346 M	USA
Arcturus Therapeutics Holdings ARCT	248 M	$ 8.11	-1.44 %	$ 219 M	Israel
Ardelyx ARDX	95.9 M	$ 6.32	-3.54 %	$ 1.52 B	USA
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
argenx SE ARGX	2.27 B	$ 762.51	-0.58 %	$ 25 B	Niderland